Devyser launches Genomic Blood Typing assay: All blood groups, one simple test
Devyser today announced the global launch of Devyser Genomic Blood Typing, a next-generation...
News | September 15, 2019
Cancer is overtaking heart disease as the leading cause of death, according to a study published recently in The Lancet medical journal.
While heart disease remains the overall leading cause globally, the study of nearly 156k participants, across 21 countries over 11 years, has identified a trend that as living conditions improve, cancer begins to overtake heart disease. In middle-income countries cancer approaches the same rate, while in high-income countries it represents more than double the deaths of heart disease. These two diseases alone account for nearly 80% of deaths in middle-aged adults.
Devyser today announced the global launch of Devyser Genomic Blood Typing, a next-generation...
Read More
Devyser, a pioneer in advanced genetic testing solutions, proudly announces the global launch of...
Read More
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a significant...
Read More
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation...
Read More